Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Esperance Pharmaceuticals
3199
Esperance Pharmaceuticals
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.
Suggest edits
Raised
$40M
Follow us
Companies in the same industry
AbbVie
Aura Biosciences
Ritter Pharmaceuticals, Inc.
Oramed Pharmaceuticals
Neos Therapeutics, Inc.
Extrakt Chemie
BioMarck Pharmaceuticals
Nevakar
Omeros Corporation
ApoGen Biotechnologies
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$40,000,000
Venture capital (Series C) - 2016
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
$40,000,000
Venture capital (Series C)
Xconomy
Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push
Health
Science
Funding
